SRINAGAR: Medanta – The Medicity, a prominent healthcare facility, is increasingly becoming a vital destination for patients from Jammu and Kashmir seeking advanced neurotechnology services. This development signals a growing opportunity for specialised medical treatments to cater to regions with limited access to such care.
According to details received by The Chenab Times, Medanta’s Deep Brain Stimulation (DBS) program, also referred to as “brain pacemaker surgery,” is drawing patients from the Union Territory for the treatment of complex neurological conditions. These include Parkinson’s disease, dystonia, epilepsy, essential tremor, and obsessive-compulsive disorder (OCD).
The hospital has incorporated cutting-edge technologies in its neuro-treatment protocols. These advancements include sophisticated imaging techniques, artificial intelligence-driven brain targeting systems, and real-time neurostimulation capabilities. Such innovations are not only aimed at improving patient outcomes but also at extending Medanta’s reach to populations in areas like Jammu and Kashmir, where highly specialised medical interventions have historically been less accessible.
Neurological disorders represent a significant portion of the overall disease burden in India, accounting for approximately 10% of the total. This prevalence fuels a continuous and growing demand for advanced therapeutic options like DBS. Medanta’s services are further enhanced by the integration of remote programming and adaptive DBS technology. This allows for reduced follow-up travel requirements for patients, making the treatment regimen more manageable and cost-effective for individuals travelling from outside the immediate hospital vicinity.
The positive outcomes observed in patients from Jammu and Kashmir, including those from districts such as Jammu and Udhampur, underscore the clinical effectiveness of the DBS therapy. This success is also contributing to an expanding referral network, positioning Medanta’s DBS treatment as a noteworthy contributor to the evolving landscape of medical value travel within India. The enhanced accessibility and technological sophistication offered by Medanta are providing a new avenue for neurological care for patients who previously faced considerable barriers in accessing such specialised medical services.
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk
 treatment for neurological disorders, providing a new healthcare avenue for patients from Jammu and Kashmir.){kind=link}